Compare Biogen Inc (BIIB) vs Costco Wholesale Corporation (COST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Costco Wholesale Corporation — how do they compare? Biogen Inc trades at $205.85 (market cap $30.13B), while Costco Wholesale Corporation trades at $947.94 (market cap $418.79B). The key difference: Costco Wholesale Corporation is far larger — about 13.9× Biogen Inc's market cap, and Costco Wholesale Corporation pays a 0.62% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | COST | |
|---|---|---|
Market Cap | $30.13B | $418.79B |
Sector | Health | Consumer Staples |
52-Week High | $216.63 | $1.09K |
52-Week Low | $128.93 | $849.63 |
Enterprise Value | $37.20B | $406.93B |
Dividend Yield | — | 0.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Biogen (BIIB) trades at $207.13, down 0.39% on the day, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings of $3.60 per share beat estimates, driven by growth in Alzheimer's and rare disease portfolios, though revenue growth remains modest. The company completed the acquisition of RayThera Inc. in August 2026, enhancing its immunology pipeline. Cash flow from operations remains healthy at $2.20 billion for 2025, supporting strategic investments.
The outlook is positive with a consensus price target of $234.47, implying ~13% upside, but risks include competitive pressures in multiple sclerosis drugs and execution challenges from recent acquisitions. Net income margin compression to 8.32% in 2026 warrants monitoring, though institutional buying and bullish analyst ratings (62.5% Buy) signal confidence in the turnaround story.
COST trades at $952.75, up 0.52% today, with a neutral technical signal. The stock shows strong fundamentals, including revenue growth to $275.24B in 2025 and consistent earnings beats, though Q1 2026 missed estimates. Positive sentiment is driven by a 65.52% analyst buy rating and a consensus price target of $1,120. Recent news highlights membership fee hikes and robust March sales, supporting investor confidence.
Outlook remains favorable due to steady growth and high institutional ownership, but risks include elevated valuation (P/E 47.5) and competitive pressures. The stock offers long-term potential if earnings momentum continues, though near-term volatility may persist amid market fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →
